Bringing the fundamentals into focus…
Back to NovaBridge Biosciences
How NovaBridge Biosciences stacks up
NBP · against 119 other Healthcare companies of similar size
Profitability
11/ 100
Near the bottom of its peers.
Ranked #90 of 120 · scores higher than 24% of peers
Bars: peers in each 10-point band of the profitability score23 peers with a profitability score of 10–19, including NBP · Click a bar to see the companies
Why profitability scores 11?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 97% of peers. Return on invested capital: -366.7% vs peer median 4.7%
- a lower return on assets: weaker than 79% of peers. Return on assets: -17.8% vs peer median 1.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = NBP, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NBP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 89 reported | -366.7% | -15.7% | 9% | 33% | |
| Operating marginHigher is better · 111 reported | Not reported | -6.9% | — | — | 33% |
| Return on assetsHigher is better · 125 reported | -17.8% | -6.1% | 35% | 33% | |
| Return on equityHigher is better · 116 reported | -59.1% | -11.7% | 23% | Context only | |
| Gross marginHigher is better · 128 reported | 0.0% | 42.3% | 7% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around NBP| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 592M ILS (≈$160M) | 96 | 84 | |
| 3 | 157M USD | 95 | ||
| 4 | 144.4B KRW (≈$104M) | 88 | 56 | |
| 5 | 244.2B KRW (≈$176M) | 83 | 72 | |
| 87 | 198M USD | 13 | 10 | |
| 88 | 217M AUD (≈$143M) | 12 | 43 | |
| 88 | 227M USD | 12 | 24 | |
| 90 | 205M USD | 11 | 36 | |
| 90 | 117M USD | 11 | 40 | |
| 90 | 284M AUD (≈$188M) | 11 | 36 | |
| 93 | 7.2B TWD (≈$224M) | 10 | 41 | |
| 93 | 126M USD | 10 | 32 | |
| 95 | 172M USD | 8 | 41 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score